0 rating

Scleroderma and Fibrosing Disorders: Advances in Management

Veena Rao, MD1, and Dinesh Khanna, MD, MS2

Systemic sclerosis (SSc) is associated with major morbidity and mortality. SSc can be a major clinical challenge and this article provides a practical approach to the management and treatment of SSc and its complications. We also discuss a growing number of exciting potential novel approaches to treatment that are moving into the clinical arena in SSc. Int J Adv Rheumatol 2010;8(2):53–62.

Return to top

RELATED ARTICLES

Anti-Citrullinated Protein Antibodies as a Risk Factor for Rheumatoid Arthritis
Diane van der Woude, MD, and Tom WJ Huizinga, MD, PhD
International Journal of Advances in Rheumatology
The Economics of Rheumatoid Arthritis Management
Daniel H Solomon, MD, MPH1, and Arthur F Kavanaugh, MD2
International Journal of Advances in Rheumatology
A Question and Answer Approach to Rheumatoid Arthritis Disease Activity
Daniel Aletaha, MD, and Josef Smolen, MD
International Journal of Advances in Rheumatology
Cardiovascular Risk Factors in Rheumatoid Arthritis
Hilal Maradit Kremers, MD, MSc, Cynthia S Crowson, MS, and Sherine E Gabriel, MD, MSc
CML Rheumatology
Serum Autoantibodies in Rheumatoid Arthritis
Raimon Sanmartí, MD, Maria Victoria Hernández, MD, José A Gómez-Puerta, MD, Eduard Graell, MD, and Juan D Cañete, MD, PhD
International Journal of Advances in Rheumatology
Cardiovascular Aspects of Rheumatoid Arthritis
Michael T Nurmohamed, MD, PhD
International Journal of Advances in Rheumatology

LATEST ARTICLES